Li Y, Chen E, Ren B
World J Cardiol. 2025; 17(1):101153.
PMID: 39866217
PMC: 11755126.
DOI: 10.4330/wjc.v17.i1.101153.
Da Silva K, Kumar P, Choonara Y
Wound Repair Regen. 2025; 33(1):e13251.
PMID: 39780313
PMC: 11711308.
DOI: 10.1111/wrr.13251.
Ding J, Meng T, Du R, Song X, Li Y, Gao J
World J Stem Cells. 2024; 16(12):1086-1105.
PMID: 39734477
PMC: 11669986.
DOI: 10.4252/wjsc.v16.i12.1086.
Wei Z, Zhang M, Chen M, Song Y, Wang Y
Clin Cosmet Investig Dermatol. 2024; 17:2901-2909.
PMID: 39712941
PMC: 11662919.
DOI: 10.2147/CCID.S489625.
Makkaoui N, Prasad V, Bagchi P, Carmona T, Li K, Latham O
Stem Cell Res Ther. 2024; 15(1):420.
PMID: 39533351
PMC: 11559167.
DOI: 10.1186/s13287-024-04009-3.
Cell-based therapies reverse the heart failure-altered right ventricular proteome.
Makkaoui N, Prasad V, Bagchi P, Carmona T, Li K, Latham O
Res Sq. 2024; .
PMID: 39281857
PMC: 11398576.
DOI: 10.21203/rs.3.rs-4752035/v1.
Decoded cardiopoietic cell secretome linkage to heart repair biosignature.
Garmany A, Arrell D, Yamada S, Jeon R, Behfar A, Park S
Stem Cells Transl Med. 2024; 13(11):1144-1159.
PMID: 39259666
PMC: 11555478.
DOI: 10.1093/stcltm/szae067.
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities.
Zhidu S, Ying T, Rui J, Chao Z
Stem Cell Res Ther. 2024; 15(1):266.
PMID: 39183341
PMC: 11346273.
DOI: 10.1186/s13287-024-03885-z.
Mesenchymal stem cell secretome: A promising therapeutic strategy for erectile dysfunction?.
Margiana R, Pilehvar Y, Amalia F, Lestari S, Supardi S, Itishom R
Asian J Urol. 2024; 11(3):391-405.
PMID: 39139521
PMC: 11318444.
DOI: 10.1016/j.ajur.2024.02.003.
The role of cardiac microenvironment in cardiovascular diseases: implications for therapy.
Yao J, Chen Y, Huang Y, Sun X, Shi X
Hum Cell. 2024; 37(3):607-624.
PMID: 38498133
DOI: 10.1007/s13577-024-01052-3.
Injectable hydrogel-based combination therapy for myocardial infarction: a systematic review and Meta-analysis of preclinical trials.
Gao H, Liu S, Qin S, Yang J, Yue T, Ye B
BMC Cardiovasc Disord. 2024; 24(1):119.
PMID: 38383333
PMC: 10882925.
DOI: 10.1186/s12872-024-03742-0.
Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective.
Sajjad M, Muzamil F, Sabir M, Ashfaq U
Curr Stem Cell Res Ther. 2024; 20(1):50-71.
PMID: 38343052
DOI: 10.2174/011574888X263530230921074827.
Enhanced Osteocyte Differentiation: Cathepsin D and L Secretion by Human Adipose-Derived Mesenchymal Stem Cells.
Choi J, Lim S, Jung S, Jeong S, Moon H, Song B
Cells. 2023; 12(24).
PMID: 38132172
PMC: 10742070.
DOI: 10.3390/cells12242852.
Extracellular vesicles from differentiated stem cells contain novel proangiogenic miRNAs and induce angiogenic responses at low doses.
Kesidou D, Bennett M, Monteiro J, McCracken I, Klimi E, Rodor J
Mol Ther. 2023; 32(1):185-203.
PMID: 38096818
PMC: 10787168.
DOI: 10.1016/j.ymthe.2023.11.023.
Cell Therapy in the Treatment of Coronary Heart Disease.
Chepeleva E
Int J Mol Sci. 2023; 24(23).
PMID: 38069167
PMC: 10706847.
DOI: 10.3390/ijms242316844.
Stem Cell-Based Therapy and Cell-Free Therapy as an Alternative Approach for Cardiac Regeneration.
Deszcz I
Stem Cells Int. 2023; 2023:2729377.
PMID: 37954462
PMC: 10635745.
DOI: 10.1155/2023/2729377.
Stem Cell-Based or Cell-Free Gene Therapy in Chondrocyte Regeneration: Synovial Fluid-Derived Mesenchymal Stem Cell Exosomes.
Uysal O, Erybeh H, Canbek M, Qomi Ekenel E, Gunes S, Buyukkoroglu G
Curr Mol Med. 2023; 24(7):906-919.
PMID: 37859306
PMC: 11327740.
DOI: 10.2174/0115665240266016231014081916.
Nanotopographical Cues Tune the Therapeutic Potential of Extracellular Vesicles for the Treatment of Aged Skeletal Muscle Injuries.
Wang K, Frey N, Garcia A, Man K, Yang Y, Gualerzi A
ACS Nano. 2023; 17(20):19640-19651.
PMID: 37797946
PMC: 10603813.
DOI: 10.1021/acsnano.3c02269.
Cardiac tissue engineering for the treatment of hypoplastic left heart syndrome (HLHS).
Abraham R, Vricella L, Hibino N
Transl Pediatr. 2023; 12(8):1592-1600.
PMID: 37692536
PMC: 10485645.
DOI: 10.21037/tp-23-127.
Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling.
Fan L, Meng C, Wang X, Wang Y, Li Y, Lv S
Clinics (Sao Paulo). 2023; 78:100263.
PMID: 37557005
PMC: 10432917.
DOI: 10.1016/j.clinsp.2023.100263.